Further, when OVA-airway inflammation model mice were intranasally administered recombinant adenovirus expressing SCGB3A2 before OVA challenge, OVA-induced airway inflammation was suppressed with airway overexpression of SCGB3A2 [6]. Here, SCGB3A2 is linked to inflammatory response.